HER2 activating mutations act as oncogenic drivers in various cancer types. In the clinic,
they can be identified by next generation sequencing (NGS) in either tumor biopsies or …

BK polyomavirus (BKV) is an important cause of graft loss in renal transplant recipients that
continues to pose a significant challenge to clinicians due to its frequently unpredictable …

The aim of this study was to identify potential proteomic biomarkers for chronic active
antibody-mediated rejection (CAMR) in kidney transplant recipients (KTRs). Among 385 …

This study aimed to determine the impact of tacrolimus (TAC) trough level (C0) intrapatient
variability (IPV) over a period of 2 years after kidney transplantation (KT) on allograft …

BACKGROUND Polyomavirus-associated nephropathy is a leading cause of kidney allograft
failure. Therapeutic options are limited and prompt reduction of the net state of …

We evaluated the overall performance of the Cobas 6800 BKV test in detecting BK virus
(BKV). We examined the imprecision of the Cobas 6800 BKV test and compared the …

Background Urine exosomal bkv-miR-B1-5p is associated with BK virus (BKV) nephropathy
(BKVN); however, its posttransplantation changes and predictability for BKVN have not been …

The objective of this study was to establish a more sensitive and specific diagnostic method
for detecting plasma BK polyomavirus (BKPyV) DNA load in patients after renal …

BK virus (BKV) is a polyomavirus with high seroprevalence in the general population with an
unremarkable clinical presentation in healthy people, but a potential for causing serious …

Introduction As there is no specific antiviral treatment currently available for BK polyomavirus
associated nephropathy (BKVAN), its management relies on immunosuppression reduction …